Weekend reads: FDA nominee authorship questions; low economics replication rates
The week at Retraction Watch featured a mysterious retraction from PLOS ONE, and a thoughtful piece by a scientist we’ve covered frequently on where we went wrong in that coverage. Here’s what was happening elsewhere: